4,4,5,5-Tetramethyl-2-(4-methylthiophen-3-yl)-1,3,2-dioxaborolane, 98%, 1g

2-[4-(3,4-dichlorophenyl)-1,3-thiazol-2-yl]acetonitrile, 97%, 250mg

1H-Pyrrole-2,5-dione, 3-[1-[3-(dimethylamino)propyl]-1H-indol-3-yl]-4-(1H-indol-3-yl)-, 99%, 10mg

Ammonium iron(III) citrate solution, 20 ml, 10 x 2 ml

7-(2-CHLOROETHOXY)-N-(3-ETHYNYLPHENYL)-6-(2-METHOXYETHOXY)QUINAZOLIN-4-AMINE, 98%, 25mg

(S)-2-((((9H-FLUOREN-9-YL)METHOXY)CARBONYL)AMINO)-4-(4-(TERT-BUTOXY)PHENYL)BUTANOIC ACID, 95%, 100mg

3-(2,3-dimethoxyphenyl)-1,2-oxazol-5-ol, 95.0%, 2g

Ethyl 4,4,4-trifluorobutyrate, 96.0%, 5g

Cyclopent-1-ene-1,2-dicarboxylic acid, 95+%, 1g

2-Fluorobutan-1-amine hydrochloride, 97%, 100mg

2-Nitrophenylarsonic Acid>98.0%(T)25g

2-(3-((TERT-BUTOXYCARBONYL)AMINO)OXETAN-3-YL)ACETIC ACID, 95.0%, 1g

1-Benzyl D-Glutamate>98.0%(HPLC)(T)5g